Equities

Cannabis Suisse Corp

CSUI:PKC

Cannabis Suisse Corp

Actions
  • Price (USD)0.0224
  • Today's Change0.00 / 0.00%
  • Shares traded500.00
  • 1 Year change-55.20%
  • Beta-3.4092
Data delayed at least 15 minutes, as of May 22 2024 14:36 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Cannabis Suisse Corp. is engaged in the business of production of over the counter (OTC) products, such as cannabidiol (CBD) oils, retail branded cigarettes and also some health-related supplements. The Company's products include Flavored Broad-Spectrum CBD Oils and CBD Isolate Tinctures with no tetrahydrocannabinol (THC). Flavored Broad-Spectrum CBD Oils products come in one fluid ounce (30 milliliters (ml)) bottles available in two flavors, such as Creme de Menthe and Cherry Vanilla. Its available CBD concentrations are 1500 milligrams (mg), 2500 mg and 3500 mg. CBD Isolate Tinctures with no THC products come in one fluid ounce (30 ml) bottles with 1000 mg CBD concentrations per bottle and 33.33 mg CBD per serving. CBD Tinctures are designed to have therapeutic effects.

  • Revenue in USD (TTM)30.00k
  • Net income in USD-254.75k
  • Incorporated2016
  • Employees--
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
CTT Pharmaceutical Holdings Inc0.00-1.67m1.39m0.00--0.7799-----0.0822-0.08220.000.03460.00-------317.2813.49-448.83304.48------------0.00-------3,454.52------
LadRx Corp0.001.66m1.41m2.000.82754.090.8436--3.443.440.000.69730.00----0.0096.28-58.97---78.44------------0.00------106.96------
Agentix Corp0.00-1.01m1.42m-----------0.0253-0.02530.00-0.0710.00-------907.08-----------------96.41----------------
Bluejay Diagnostics Inc0.00-9.74m1.45m10.00--0.3976-----7.68-7.680.001.250.00----0.00-122.06---149.68--------------0.0048---100.00---7.07------
Drazcanna Inc2.05m-5.71m1.47m--------0.7192-0.7024-0.70240.24920.10040.685--23.88---191.19---643.20---11.20---279.10-----33.040.2445--------------
Yield10 Bioscience Inc300.00k-13.15m1.48m29.00------4.93-146.30-146.301.06-123.900.0627----10,344.83-274.51-91.26-2,396.54-108.09-----4,381.67-2,279.74---------86.67-35.94-6.55--1.84--
Virpax Pharmaceuticals Inc0.00-16.89m1.52m7.00---------14.42-14.420.00-1.040.00----0.00-156.21-87.52-241.52-116.56--------------------29.84------
Dermata Therapeutics Inc0.00-8.69m1.54m8.00--6.08-----24.67-24.670.000.57170.00----0.00-120.05---146.08--------------0.00------18.90------
GRI Bio Inc0.00-12.77m1.56m4.00--0.4718-----26.90-26.900.000.87530.00----0.00-382.23-192.93-869.57-353.99-------37,650.49---16.800.00-------85.61--29.46--
180 Life Sciences Corp0.00-16.24m1.56m4.00---------41.54-41.540.00-1.120.00----0.00-176.90-42.39-354.57-56.41-----------385.88--------48.52------
Cannabis Suisse Corp30.00k-254.75k1.58m--------52.66-0.0057-0.00570.0007-0.01030.0675-------57.35-149.71-238.71--8.37-39.11-849.17-427.20---13.573.38--28.709.00-87.10------
Mallinckrodt PLC1.91bn-1.49bn1.60m2.80k------0.0008-161.65-161.6389.6355.440.40621.574.94681,821.40-31.61-12.49-36.10-15.8526.2235.68-77.83-44.381.63-0.34560.6164---2.53-10.31-83.00------
Stemcell Holdings Inc9.98m3.10m1.64m------0.50080.16450.000080.000080.00030.00021.12--5.20--34.90--68.19--77.19--31.04------0.00--85.10--71.82------
Procyon Corp4.70m-314.48k1.70m17.00--0.7633--0.3614-0.0388-0.03880.58040.29011.401.958.58276,481.20-8.903.52-10.604.2377.6073.30-6.352.522.70--0.00---3.223.1170.44--30.98--
InVitro International716.89k6.22k1.71m16.00214.292.33--2.380.00040.00040.04020.03211.15------0.9957.891.098.83----0.86765.90---------5.111.33-87.77-16.14----
SOHM Inc-100.00bn-100.00bn1.76m--------------------------------------------------------------
Data as of May 22 2024. Currency figures normalised to Cannabis Suisse Corp's reporting currency: US Dollar USD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.